Log in
Leukaemia CARE
606 members291 posts

Dr Manos Nikolousis discusses new drugs now available to treat Acute Myeloid Leukaemia (AML)

AML treatment is moving from being a standard treatment to a personalised treatment. Dr Manos Nikolousis, Clinical Director at Haematology / Stem cell transplantation Heart of England NHS Trust talks about these advancements.

1 Reply

I think the move from standard treatment to personalised treatment is brilliant and definitely the way forward. Thanks for this and take care.


You may also like...